Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00101465 · ClinicalTrials.gov registry record
Partnership Programs for Reducing Cardiovascular Disparities in Native Hawaiians
A clinical trial, sponsored by University of Hawaii.
- Completed
- Registry status
- 276
- Enrollment target
NCT00101465: Completed study, sponsored by University of Hawaii.
NCT00101465 is a clinical trial that has completed, run by University of Hawaii. The registered enrollment target is 276 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00101465 has completed, sponsored by University of Hawaii.
- COMPLETED
- Registry status
- 276 participants
- Enrollment target
Study Summary
The purpose of this study is to improve cardiovascular disease (CVD) outcomes in racial and ethnic minorities in Hawaii.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 276 participants |
| Start Date | 2004-09 |
| Est. Completion | 2011-08 |
What the finished NCT00101465 record still lists
NCT00101465 is an observational study that tracks outcomes without assigning an intervention. The registered 276 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00101465 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00101465 about?
NCT00101465 is a clinical study titled "Partnership Programs for Reducing Cardiovascular Disparities in Native Hawaiians". The purpose of this study is to improve cardiovascular disease (CVD) outcomes in racial and ethnic minorities in Hawaii.
What is the current status of trial NCT00101465?
This trial is currently completed. The enrollment target is 276 participants. The study started on 2004-09. Estimated completion is 2011-08.
Who is sponsoring clinical trial NCT00101465?
This trial is sponsored by University of Hawaii, which has 77 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01371630 · 276 participants · Phase 1
Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia
- NCT04192344 · 276 participants · Phase 1
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor
- NCT05294991 · 276 participants · NA
Wellness App for Sleep Disturbance in Hematological Cancer Patients
- NCT05610852 · 276 participants · NA
Single-Port Transvesical Partial Prostatectomy Versus High Intensity Focused Ultrasound
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia